Mannheimia haemolytica (Newsom and Cross) Angen et al 拉丁名
(ATCC? 31611? )統(tǒng)一編號
Deposited As Pasteurella haemolytica Newsom and Cross
Strain Designations 別名 76-72H (Parent)
Application
Used to produce vaccine against Pasteurella haemolytica
Isolation 用途 Calf lung, Nebraska
Biosafety Level 生物安全等級 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol? no
Type Strain 模式菌株 no
Medium 培養(yǎng)基 ATCC? Medium 1206: Tryptose broth with thiamine
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度 : 37.0°C
Name of Depositor 寄存者 Norden Labs
.U.S. Patent Number 4,328,210
References 參考文獻 Kucera CJ. Modified Pasteurella bacteria and vaccines prepared therefrom. US Patent 4,388,299 dated Jun 14 1983
Kucera CJ. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom. US Patent 4,626,430 dated Dec 2 1986